↓ Skip to main content

The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in oncology, August 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia
Published in
Frontiers in oncology, August 2019
DOI 10.3389/fonc.2019.00705
Pubmed ID
Authors

Laura Monaghan, Matthew E. Massett, Roderick P. Bunschoten, Alex Hoose, Petrisor-Alin Pirvan, Robert M. J. Liskamp, Heather G. Jørgensen, Xu Huang

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 128 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 20%
Researcher 17 13%
Student > Master 17 13%
Student > Bachelor 14 11%
Student > Doctoral Student 6 5%
Other 17 13%
Unknown 31 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 48 38%
Medicine and Dentistry 13 10%
Agricultural and Biological Sciences 11 9%
Chemistry 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 7 5%
Unknown 40 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2019.
All research outputs
#20,674,485
of 25,394,764 outputs
Outputs from Frontiers in oncology
#11,324
of 22,440 outputs
Outputs of similar age
#273,180
of 359,129 outputs
Outputs of similar age from Frontiers in oncology
#182
of 302 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,440 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,129 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 302 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.